Pharmaceutical Market Europe • May 2025 • 5
CONTENTS
May 2025
NEWS & COLUMNS
6-7 NEWS
GSK and ABL agree on £2bn deal; Biogen/Eisai’s Alzheimer’s drug granted EC approval
8-9 NEWS
Ipsen’s elafibranor shows potential; Roche commits $50bn to boost US footprint
10-11 DERMATOLOGY NEWS
Sanofi/Regeneron drug gets FDA approval for urticaria; J&J’s phase 3 results for Tremfya
12 DARWIN'S MEDICINE
Darwin's dictum on data
13 PATIENT PARTNERSHIPS
It’s not about just engaging with patients, it's about making them integral at every stage
14 INNOVATIVE IMPACT
Why local market input is the early commercialisation superpower
15 HEALTH EQUITY
The real challenge to achieving health equity lies in translating awareness into tangible action
FEATURES
16-17 SHAPING THE FUTURE OF CANCER CARE
Advancing immunotherapies, ADCs and combination approaches
18-19 ACCELERATING ACCESS TO RARE DISEASE TREATMENTS
Advancing rare disease research through global collaborations and unified clinical trials
20-21 THE IMPACT OF DUCHENNE MUSCULAR DYSTROPHY
Global research, available treatments and why early diagnosis is essential in this rare disease
25-33 CELEBRATING COMMUNICATIONS EXCELLENCE
As the world continues to adapt and evolve amid great global uncertainty, this special feature explores the most important topics affecting the healthcare communications industry today
COMMUNIQUE
MARKETING & COMMS
34-36 RISING TO MEET THE CHALLENGES OF CLINICAL TRIALS
The struggle to make clinical trials easier to conduct and more attractive to patients while understanding the impact of human behaviour and everyday pressures
38-39 ACHIEVING GENDER PARITY FOR WOMEN IN CLINICAL TRIALS
The importance of putting flexibility at the core of trials to make them more accessible for women
40-41 MAXIMISING THE POTENTIAL OF AI IN PHARMA
AI can help to create a new era of data-driven, personalised healthcare that enhances clinical outcomes and healthcare access for all
47 HEALTHCARE COMMS
IPG Health launches new agency Vio; Springer Healthcare and inScience rebrand
CAREERS & RECRUITMENT
43 PHARMA MARKETING JOBS
Visit our new website for all
your recruiting needs!
44-46 APPOINTMENTS
Changes at Sanofi, Novo Nordisk and the FDA